Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 8
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abataceptDivya Koura, Dimitrios Tzachanis, James Mirocha et al.|Blood Advances|2025Cited by 7
A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-Free Graft-Versus-Host Disease Prophylaxis Regimen with Post-Transplantation Cyclophosphamide and Abatacept to Standard of CareDivya Koura, Kimberly McConnell, Dimitrios Tzachanis et al.|Blood|2021Cited by 2
A Prospective Randomized Clinical Trial Comparing a Calcineurin-Free Gvhd Prophylaxis Regimen with Post-Transplant Cyclophosphamide and Abatacept to Methotrexate and TacrolimusDivya Koura, Dimitrios Tzachanis, James Mirocha et al.|Blood|2023Cited by 1
A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin LymphomaSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Blood|2019Cited by 0